Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

A Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

Niihara Y, Miller ST, Kanter J, Lanzkron S, Smith WR, Hsu LL, Gordeuk VR, Viswanathan K, Sarnaik S, Osunkwo I, Guillaume E, Sadanandan S, Sieger L, Lasky JL, Panosyan EH, Blake OA, New TN, Bellevue R, Tran LT, Razon RL, Stark CW, Neumayr LD, Vichinsky EP; Investigators of the Phase 3 Trial of l-Glutamine in Sickle Cell Disease.

N Engl J Med. 2018 Jul 19;379(3):226-235. doi: 10.1056/NEJMoa1715971.

PMID:
30021096
2.

Efficacy of Asparaginase Erwinia chrysanthemi With and Without Temozolomide Against Glioma Cells and Intracranial Mouse Medulloblastoma.

Sanghez V, Chen M, Li S, Chou TF, Iacovino M, Lin HJ, Lasky JL, Panosyan EH.

Anticancer Res. 2018 May;38(5):2627-2634.

PMID:
29715082
3.

In search of druggable targets for GBM amino acid metabolism.

Panosyan EH, Lin HJ, Koster J, Lasky JL 3rd.

BMC Cancer. 2017 Feb 28;17(1):162. doi: 10.1186/s12885-017-3148-1.

4.

Clinical aggressiveness of malignant gliomas is linked to augmented metabolism of amino acids.

Panosyan EH, Lasky JL, Lin HJ, Lai A, Hai Y, Guo X, Quinn M, Nelson SF, Cloughesy TF, Nghiemphu PL.

J Neurooncol. 2016 May;128(1):57-66. doi: 10.1007/s11060-016-2073-5. Epub 2016 Feb 27.

5.

Use of a Pediatric Bleeding Questionnaire in the Screening of Von Willebrand Disease in Young Females at Menarche in the Primary Care Setting.

Duran J, Lasky JL 3rd, Rodgers C.

J Pediatr Health Care. 2016 Sep-Oct;30(5):408-13. doi: 10.1016/j.pedhc.2015.10.005. Epub 2015 Nov 25.

PMID:
26614275
6.

Clinicocytopathologic correlation in an atypical presentation of lymphadenopathy with review of literature.

Choi AH, Bolaris M, Nguyen DK, Panosyan EH, Lasky JL 3rd, Duane GB.

Am J Clin Pathol. 2015 May;143(5):749-54. doi: 10.1309/AJCPPSKWRX0GD8HJ. Review.

PMID:
25873511
7.

Asparagine depletion potentiates the cytotoxic effect of chemotherapy against brain tumors.

Panosyan EH, Wang Y, Xia P, Lee WN, Pak Y, Laks DR, Lin HJ, Moore TB, Cloughesy TF, Kornblum HI, Lasky JL 3rd.

Mol Cancer Res. 2014 May;12(5):694-702. doi: 10.1158/1541-7786.MCR-13-0576. Epub 2014 Feb 6.

8.

Autologous tumor lysate-pulsed dendritic cell immunotherapy for pediatric patients with newly diagnosed or recurrent high-grade gliomas.

Lasky JL 3rd, Panosyan EH, Plant A, Davidson T, Yong WH, Prins RM, Liau LM, Moore TB.

Anticancer Res. 2013 May;33(5):2047-56.

9.

High-dose chemotherapy with autologous hematopoietic stem-cell rescue for pediatric brain tumor patients: a single institution experience from UCLA.

Panosyan EH, Ikeda AK, Chang VY, Laks DR, Reeb CL, Bowles LV, Lasky JL 3rd, Moore TB.

J Transplant. 2011;2011:740673. doi: 10.1155/2011/740673. Epub 2011 Apr 14.

10.

"Primary" leptomeningeal medulloblastoma.

Mehta RI, Cutler AR, Lasky JL 3rd, Yong WH, Lerner JT, Hirota BK, Salamon N, Mathern GW, Vinters HV.

Hum Pathol. 2009 Nov;40(11):1661-5. doi: 10.1016/j.humpath.2009.04.024. Epub 2009 Aug 19.

PMID:
19695677
11.

Index of suspicion.

Bekmezian A, Lasky JL 3rd, Osman S, Kaddurah AK, Varela AM, Velez K, Alvarez O.

Pediatr Rev. 2009 Aug;30(8):311-6. doi: 10.1542/pir.30-8-311. No abstract available.

PMID:
19648262
12.

Cancer stem cells in pediatric brain tumors.

Lasky JL 3rd, Choe M, Nakano I.

Curr Stem Cell Res Ther. 2009 Dec;4(4):298-305. Review.

PMID:
19500067
13.

Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation.

Guo W, Lasky JL, Chang CJ, Mosessian S, Lewis X, Xiao Y, Yeh JE, Chen JY, Iruela-Arispe ML, Varella-Garcia M, Wu H.

Nature. 2008 May 22;453(7194):529-33. doi: 10.1038/nature06933. Epub 2008 May 7.

14.

Congenital brain tumors: case series and review of the literature.

Lasky JL, Choi EJ, Johnston S, Yong WH, Lazareff J, Moore T.

J Pediatr Hematol Oncol. 2008 Apr;30(4):326-31. doi: 10.1097/MPH.0b013e3181647bf0.

PMID:
18391706
15.

Abducens nerve ocular neuromyotonia following non-sellar or parasellar tumors.

Ela-Dalman N, Arnold AC, Chang LK, Velez FG, Lasky JL 3rd.

Strabismus. 2007 Jul-Sep;15(3):149-51.

PMID:
17763251
16.

Treatment of embryonal rhabdomyosarcoma of the sinus and orbit with chemotherapy, radiation, and endoscopic surgery.

Luu QC, Lasky JL, Moore TB, Nelson S, Wang MB.

J Pediatr Surg. 2006 Jun;41(6):e15-7.

PMID:
16769322
17.

Targeting stem cells in brain tumors.

Lasky JL, Liau LM.

Technol Cancer Res Treat. 2006 Jun;5(3):251-60. Review.

PMID:
16700621
18.

Cancer stem cells.

Guo W, Lasky JL 3rd, Wu H.

Pediatr Res. 2006 Apr;59(4 Pt 2):59R-64R. Review.

PMID:
16549550
19.

Notch signaling, brain development, and human disease.

Lasky JL, Wu H.

Pediatr Res. 2005 May;57(5 Pt 2):104R-109R. Epub 2005 Apr 6. Review.

PMID:
15817497
20.

Reticulum cell sarcomas of SJL mice have rearranged immunoglobulin heavy and light chain genes.

Stavnezer J, Lasky JL, Ponzio NM, Scheid MP, Thorbecke GJ.

Eur J Immunol. 1989 Jun;19(6):1063-9.

PMID:
2546779
22.

Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.

Lasky JL, Ponzio NM, Thorbecke GJ.

J Immunol. 1988 Jan 15;140(2):679-87. Erratum in: J Immunol 1988 Apr 1;140(7):2478.

PMID:
3275720
23.

Growth requirements of SJL lymphomas in vitro: effect of BCGF II.

Lasky JL, Thorbecke GJ.

Adv Exp Med Biol. 1988;237:145-53. No abstract available.

PMID:
3151036

Supplemental Content

Loading ...
Support Center